Product Comparison


 

No Image

Seqirus USA Inc 70461042110
Seqirus USA Inc 70461032103
Seqirus USA Inc 70461012103
Seqirus USA Inc 33332042110
McKesson # 809439 1183068 1183069 1183071 1183078
Description Humiraᆴ Crohn's Disease Starter Pack Adalimumab, Preservative Free 40 mg / 0.8 mL Injection Prefilled Auto-Injector Pen 6 Doses Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Multiple Dose Vial 5 mL Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL FLUAD™ 2021 - 2022 Flu Vaccine, Adjuvanted 45 mcg / 0.5 mL Indicated For People 65 Years of Age and Above Prefilled Syringe 0.5 mL Afluria® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Above Multiple Dose Vial 5 mL
Manufacturer # 0007443390670461042110704610321037046101210333332042110
Brand  Flucelvax® Quadrivalent 2021 - 2022Flucelvax® Quadrivalent 2021 - 2022FLUAD™ 2021 - 2022Afluria® Quadrivalent 2021 - 2022
Manufacturer AbbVie IncSeqirus USA IncSeqirus USA IncSeqirus USA IncSeqirus USA Inc
Invoice  FLUCELVAX 2021, QUAD MDV 5ML (10DOSE/VL)FLUCELVAX 2021, QUAD SYR 0.5ML(10DOSE/BX)FLUAD 2021, QUAD SYR 0.5ML 65+YEAR ADJ (10DOSE/BX)AFLURIA 2021, QUAD MDV 5ML (10DOSE/VL)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 1586619
Application Flu VaccineFlu VaccineFlu Vaccine, AdjuvantedFlu Vaccine
Container Type Multiple Dose VialPrefilled SyringePrefilled SyringeMultiple Dose Vial
Country of Origin UnknownUnited StatesUnited StatesUnited StatesAustralia
Dosage Form InjectionInjectionInjectionInjection
Generic Drug Code 4960649583
NDC Number 70461042110704610321037046101210333332042110
Product Dating McKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 60 mcg / 0.5 mL60 mcg / 0.5 mL45 mcg / 0.5 mL60 mcg / 0.5 mL
Type IntramuscularIntramuscularIntramuscularIntramuscular
UNSPSC Code 51201608512016085120160851201608
User Indicated For People 6 Months of Age and AboveIndicated For People 6 Months of Age and AboveIndicated For People 65 Years of Age and AboveIndicated For People 6 Months of Age and Above
Volume 5 mL0.5 mL0.5 mL5 mL
Features and Benefits
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX QUADRIVALENT is approved for use in persons 6 Months of age and older
  • FLUCELVAX QUADRIVALENT 5 mL multi-dose vial formulation contains no antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX Quadrivalent is approved for use in persons 6 Months of age and older
  • FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative or antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUAD is approved for use in persons 65 years of age and older
  • Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2021 - 2022 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus)
  • FLUAD also contains MF59C.1 adjuvant (MF59®), a squalene based oil-in-water emulsion
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 6 Months and older
  • The multi-dose presentation contains thimerosal added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2021 - 2022 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.